Addressing the Opioid Crisis-The Need for a Pain Management Intervention in Community Pharmacies in Canada: A Narrative Review
- PMID: 37104077
- PMCID: PMC10144945
- DOI: 10.3390/pharmacy11020071
Addressing the Opioid Crisis-The Need for a Pain Management Intervention in Community Pharmacies in Canada: A Narrative Review
Abstract
Background: The opioid crisis is a public health concern in Canada with a continued rise in deaths and presents a significant economic impact on the healthcare system. There is a need to develop and implement strategies for decreasing the risk of opioid overdoses and other opioid-related harms resulting from the use of prescription opioids. Pharmacists, as medication experts and educators, and as one of the most accessible frontline healthcare providers, are well positioned to provide effective opioid stewardship through a pain management program focused on improving pain management for patients, supporting appropriate prescribing and dispensing of opioids, and supporting safe and appropriate use of opioids to minimize potential opioid misuse, abuse, and harm. Methods: A literature search was conducted in PubMed, Embase and grey literature to determine the characteristics of an effective community pharmacy-based pain management program, including the facilitators and barriers to be considered. Discussion: An effective pain management program should be multicomponent, address other co-morbid conditions in addition to pain, and contain a continuing education component for pharmacists. Solutions to implementation barriers, including pharmacy workflow; addressing attitudes beliefs, and stigma; and pharmacy remuneration, as well as leveraging the expansion of scope from the Controlled Drugs and Substances Act exemption to facilitate implementation, should be considered. Conclusions: Future work should include the development, implementation, and evaluation of a multicomponent, evidence-based intervention strategy in Canadian community pharmacies to demonstrate the impact pharmacists can have on the management of chronic pain and as one potential solution to helping curb the opioid crisis. Future studies should measure associated costs for such a program and any resulting cost-savings to the healthcare system.
Keywords: community pharmacy; opioid crisis; pain management; prescription opioids.
Conflict of interest statement
All authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location.J Opioid Manag. 2021 Jan-Feb;17(1):19-38. doi: 10.5055/jom.2021.0611. J Opioid Manag. 2021. PMID: 33735425
-
The opioid crisis: Origins, trends, policies, and the roles of pharmacists.Am J Health Syst Pharm. 2019 Mar 19;76(7):424-435. doi: 10.1093/ajhp/zxy089. Am J Health Syst Pharm. 2019. PMID: 31361827 Review.
-
The Role of the Pharmacist in Combating the Opioid Crisis: An Update.Subst Abuse Rehabil. 2022 Dec 28;13:127-138. doi: 10.2147/SAR.S351096. eCollection 2022. Subst Abuse Rehabil. 2022. PMID: 36597518 Free PMC article. Review.
-
Promising roles for pharmacists in addressing the U.S. opioid crisis.Res Social Adm Pharm. 2019 Aug;15(8):910-916. doi: 10.1016/j.sapharm.2017.12.009. Epub 2017 Dec 31. Res Social Adm Pharm. 2019. PMID: 29325708 Free PMC article.
-
A Systematic Review of Interventions and Programs Targeting Appropriate Prescribing of Opioids.Pain Physician. 2019 May;22(3):229-240. Pain Physician. 2019. PMID: 31151331
Cited by
-
Advancing opioid stewardship in low-middle-income countries: challenges and opportunities.J Pharm Policy Pract. 2024 Jun 5;17(1):2345219. doi: 10.1080/20523211.2024.2345219. eCollection 2024. J Pharm Policy Pract. 2024. PMID: 38845626 Free PMC article.
-
Combatting opioid misuse, overuse and abuse: a systematic review of pharmacists' services and outcomes.Pain Manag. 2024 Sep;14(9):519-529. doi: 10.1080/17581869.2024.2411930. Epub 2024 Oct 22. Pain Manag. 2024. PMID: 39439259
-
Cannabis use and illicit opioid cessation among people who use drugs living with chronic pain.Drug Alcohol Rev. 2025 Mar;44(3):799-810. doi: 10.1111/dar.14014. Epub 2025 Feb 26. Drug Alcohol Rev. 2025. PMID: 40011075
-
How can community pharmacy teams prevent prescription and over-the-counter opioid misuse in North East England? A qualitative study using the Capability, Opportunity and Motivation Behaviour (COM-B) model.BMJ Open. 2025 May 12;15(5):e099801. doi: 10.1136/bmjopen-2025-099801. BMJ Open. 2025. PMID: 40355287 Free PMC article.
References
-
- Public Health Agency of Canada Modelling Opioid-Related Deaths during the COVID-19 Outbreak. Government of Canada. Updated 5 August 2022. [(accessed on 12 October 2022)]. Available online: https://www.canada.ca/en/health-canada/services/opioids/data-surveillanc....
-
- Substance-Related Overdose and Mortality Surveillance Task Group (SOMS-TG) of the Special Advisory Committee (SAC) on the Epidemic of Opioid Overdoses—Public Health Agency of Canada. Apparent Opioid and Stimulant Toxicity Deaths: Surveillance of Opioid- and Stimulant-Related Harms in Canada January 2016 to March 2022. Government of Canada. Published September 2022. [(accessed on 12 October 2022)]. Available online: https://health-infobase.canada.ca/src/doc/SRHD/Update_Deaths_2022-09.pdf.
-
- Substance-Related Overdose and Mortality Surveillance Task Group (SOMS-TG) of the Special Advisory Committee (SAC) on the Epidemic of Opioid Overdoses—Public Health Agency of Canada. Opioid and Stimulant Poisoning Hospitalizations: Surveillance of Opioid- and Stimulant-Related Harms in Canada January 2016 to March 2022. Government of Canada. Published September 2022. [(accessed on 12 October 2022)]. Available online: https://health-infobase.canada.ca/src/doc/SRHD/Update_Hospitalizations_2....
-
- Canadian Centre on Substance Use and Addiction Canadian Drug Summary: Prescription Opioids. Published July 2020. [(accessed on 14 October 2022)]. Available online: https://www.ccsa.ca/sites/default/files/2020-07/CCSA-Canadian-Drug-Summa....
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources